Article Text

PDF

P92 Miliary tuberculosis: data from a modern case-series in the United Kingdom
  1. N Venkatraman1,
  2. T King1,
  3. G Woltmann1,
  4. MJ Wiselka1,
  5. D Bell1,
  6. M Pareek2
  1. 1University Hospitals of Leicester, Leicester, United Kingdom
  2. 2University of Leicester, Leicester, United Kingdom

Abstract

Background Miliary tuberculosis (mTB), a severe manifestation of TB is classically associated with a high mortality. Modern data on the management and outcomes of mTB in developed world settings are lacking. We reviewed clinico-bacteriological features of mTB cases presenting to a teaching hospital in Leicester, UK serving an ethnically diverse population.

Methods Retrospective descriptive case-series of all notified mTB cases admitted between 2007 and 2012.

Results 41 cases were identified; median age 47 years (IQR:29–65 years), 61% were male and 80.5% patients were of Indian-Subcontinent origin. 92.5% of patients were foreign-born and median time between UK arrival and diagnosis was 4 years (IQR:1–10 years). 37(90.2%) patients had an HIV test; 4 were positive (median CD4 count 60;IQR 30–140). Weight loss (87.2%) and fevers (82.9%) were the most common presenting symptoms. 30 patients (73.2%) had abnormal examination findings; predominantly respiratory (63.3%). Initial bloods were diagnostically nonspecific apart from lymphopaenia and depressed lymphocyte:monocyte ratio. All patients had radiological evidence of pulmonary miliary nodules. 28/41(68.3%) patients had neuroimaging: 14/28(50%) had neuroradiological involvement–predominantly tuberculomas (12/28–42.9%). Lumbar punctures were undertaken in 73.2% of patients but only abnormal in 5 patients (17.2%) (and only 1 with normal imaging). Overall, 16(39%) patients had evidence of CNS involvement.

32/41(78.1%) patients were culture positive (all fully-sensitive) with sputum and BAL providing the highest yield. Antituberculous therapy was commenced within a median of 1 day following hospital admission. To date, 30 patients have successfully completed treatment, 3 are still on treatment, 5 have moved away and 3(7.3%) have died. In those subjects who successfully completed therapy, the lymphocyte:monocyte ratio increased significantly (p = 0.0201). Patients who died had a longer duration between admission and commencing antituberculous treatment (median 8 days; IQR 1–16 days), than those who successfully completed treatment (median 1 day; IQR 0–3 days).

Conclusions In this developed world setting, mTB is not an uncommon presentation. Although there was a high prevalence of co-existing neurological involvement, overall mortality was low. Undertaking diagnostic procedures for culture is important and has a high yield. Early treatment may have resulted in improved outcomes and the lymphocyte:monocyte ratio may help to monitor response to treatment in miliary TB.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.